Tower Research Capital LLC (Trc) Zynerba Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.33 - $1.39 $4,290 - $18,074	-13,003 Reduced 82.21%	2,814 $3,000
Q2 2023 Aug 14, 2023	BUY	$0.3 - $0.43 $4,719 - $6,765	15,733 Added 18729.76%	15,817 $5,000
Q1 2023 May 09, 2023	SELL	$0.4 - $0.67 $5,979 - $10,015	-14,949 Reduced 99.44%	84 $0
Q4 2022 Feb 10, 2023	SELL	$0.5 - $0.72 $7,056 - $10,161	-14,113 Reduced 48.42%	15,033 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.87 - $1.36 $23,519 - $36,766	27,034 Added 1280.02%	29,146 $21,000
Q2 2022 Aug 15, 2022	BUY	$0.86 - $2.06 $266 - $638	310 Added 17.2%	2,112 $2,000
Q1 2022 May 12, 2022	BUY	$1.83 - $3.02 $3,164 - $5,221	1,729 Added 2368.49%	1,802 $4,000
Q4 2021 Feb 14, 2022	BUY	$2.88 - $4.3 $210 - $313	73 New	73 $0
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $86,281 - $124,087	-23,194 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $88,833 - $138,700	23,194 New	23,194 $122,000
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $20,067 - $26,715	-6,213 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.31 - $6.54 $20,565 - $40,633	6,213 New	6,213 $21,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.16 $12,325 - $26,180	-4,250 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$5.61 - $8.57 $7,281 - $11,123	-1,298 Reduced 23.4%	4,250 $26,000
Q3 2019 Nov 05, 2019	BUY	$7.56 - $15.44 $1,973 - $4,029	261 Added 4.94%	5,548 $42,000
Q2 2019 Aug 13, 2019	BUY	$5.4 - $15.5 $28,549 - $81,948	5,287 New	5,287 $72,000
Q1 2019 May 14, 2019	SELL	$3.6 - $6.22 $41,389 - $71,511	-11,497 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.89 - $7.91 $31,781 - $86,986	10,997 Added 2199.4%	11,497 $35,000
Q3 2018 Nov 13, 2018	SELL	$5.59 - $10.45 $12,996 - $24,296	-2,325 Reduced 82.3%	500 $4,000
Q2 2018 Aug 15, 2018	SELL	$7.98 - $12.39 $33,428 - $51,901	-4,189 Reduced 59.72%	2,825 $28,000
Q1 2018 May 15, 2018	BUY	$8.49 - $13.46 $59,548 - $94,408	7,014 New	7,014 $61,000
Q4 2017 Feb 09, 2018	SELL	$8.69 - $14.59 $34,003 - $57,090	-3,913 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.73 - $9.44 $22,421 - $36,938	3,913	3,913 $33,000

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account